文献速递骨肿瘤关节外科

骨盆软骨肉瘤髋臼切除后重建技术的比较

Comparison of reconstructive techniques after acetabular resection for pelvic chondrosarcoma.
PubMed 文献 · Bone Joint J · 2021-01-01

本研究回顾66例因软骨肉瘤行髋臼切除的患者,比较重建与否及不同重建方式的功能与并发症。结果示重建组与未重建组行走能力和MSTS评分无差异,但钽THA重建者MSTS评分显著更高,且重建组并发症更多。

要点

  • 重建组与未重建组行走能力及MSTS评分无显著差异。
  • 钽THA重建者MSTS评分显著高于鞍状假体或未重建者。
  • 重建组并发症发生率显著高于未重建组。

核心结论

  • 髋臼切除后重建技术复杂,在选定病例中重建有益,尤其是钽THA重建,但随访仍为中短期。
  • 当重建不可行时,未重建患者的功能结果可接受。

研究设计与样本

  • 回顾性研究,纳入66例因软骨肉瘤行髋臼切除的患者,平均年龄53岁(24至81岁),平均随访9年(SD 4)。
  • 36例(54%)行髋臼重建,最常用鞍状假体(n=13;36%)或钽全髋关节置换(THA)(n=10;28%)。

主要发现

  • 重建组与未重建组在平均年龄(p=0.63)、性别(p=0.110)、肿瘤体积(p=0.646)或切除类型(p>0.05)上无差异。
  • 66例中61例(92%)末次随访时可行走,重建组与未重建组行走比例无差异(p=0.649)。
  • 重建组与未重建组平均MSTS评分无差异(61% vs 56%;p=0.378)。
  • 钽THA重建者平均MSTS评分(78%)显著高于鞍状假体重建者(47%)或未重建者(56%)(p=0.015)。
  • 重建组并发症发生率显著高于未重建组(81% vs 53%;p=0.033)。

关键数值与推荐

  • 钽THA重建者平均MSTS评分为78%,鞍状假体重建者为47%,未重建者为56%(p=0.015)。
  • 重建组并发症发生率为81%,未重建组为53%(p=0.033)。

临床怎么用

  • 对于骨盆软骨肉瘤髋臼切除后患者,可考虑在选定病例中行钽THA重建以改善功能。
  • 需告知患者重建后并发症风险较高,未重建者功能结果亦可接受。

局限性

  • 随访仍为中短期。
  • 证据等级为Level III治疗性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Hip reconstruction after resection of a periacetabular chondrosarcoma is complex and associated with a high rate of complications. Previous reports have compared no reconstruction with historical techniques that are no longer used. The aim of this study was to compare the results of tantalum acetabular reconstruction to both historical techniques and no reconstruction. METHODS: We reviewed 66 patients (45 males and 21 females) with a mean age of 53 years (24 to 81) who had undergone acetabular resection for chondrosarcoma. A total of 36 patients (54%) underwent acetabular reconstruction, most commonly with a saddle prosthesis (n = 13; 36%) or a tantalum total hip arthroplasty (THA) (n = 10; 28%). Mean follow-up was nine years (SD 4). RESULTS: There was no difference in the mean age (p = 0.63), sex (p = 0.110), tumour volume (p = 0.646), or type of resection carried out (p > 0.05) between patients with and without reconstruction. Of the original 66 patients, 61 (92%) were ambulant at final follow-up. There was no difference in the proportion of patients who could walk in the reconstruction and 'no reconstruction' groups (p = 0.649). There was no difference in the mean Musculoskeletal Tumor Society (MSTS) score between patients who were reconstructed and those who were not (61% vs 56%; p = 0.378). Patients with a tantalum THA had a significantly (p = 0.015) higher mean MSTS score (78%) than those who were reconstructed with a saddle prosthesis (47%) or who had not been reconstructed (56%). Patients who had undergone reconstruction were more likely to have complications (81% vs 53%; p = 0.033). CONCLUSION: Reconstruction after resection of the acetabulum is technically demanding. In selected cases, reconstruction is of benefit, especially when reconstruction is by tantalum THA; however, the follow-up for these patients remains mid-term. When not feasible, patients with no reconstruction have an acceptable functional outcome. Level of Evidence: Level III Therapeutic. Cite this article: Bone Joint J 2021;103-B(2):391-397.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Houdek MT, Wunder JS, Abdel MP, et al. Comparison of reconstructive techniques after acetabular resection for pelvic chondrosarcoma. Bone Joint J. 2021. PMID: 33517732. doi:10.1302/0301-620X.103B2.BJJ-2020-1012.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。